NPI: 1689944076 · KNOXVILLE, TN 37914 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/03/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/03/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,789 | $177K |
| 2019 | 12,082 | $155K |
| 2020 | 5,713 | $139K |
| 2021 | 2,643 | $135K |
| 2022 | 3,097 | $141K |
| 2023 | 3,334 | $116K |
| 2024 | 1,205 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 22,373 | 1,687 | $890K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 586 | 189 | $7K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 6,561 | 385 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,132 | 450 | $745.11 |
| J1756 | Injection, iron sucrose, 1 mg | 1,425 | 353 | $193.60 |
| 85045 | 749 | 424 | $0.00 | |
| 85041 | 548 | 498 | $0.00 | |
| 85048 | 546 | 497 | $0.00 | |
| 83970 | 756 | 538 | $0.00 | |
| 83540 | 249 | 227 | $0.00 | |
| 82108 | 40 | 35 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 1,171 | 610 | $0.00 |
| 82746 | 39 | 34 | $0.00 | |
| 82728 | 236 | 217 | $0.00 | |
| 83550 | 252 | 227 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 73 | 55 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 30 | 26 | $0.00 |
| 82607 | 40 | 35 | $0.00 | |
| 90674 | 28 | 27 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 29 | 18 | $0.00 |